Sequoia: Results of a Phase 3 Randomized Study of Zanubrutinib (Zanu) Versus Bendamustine + Rituximab (BR) in Patients (Pts) with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Authors :: Mazyar Shadman
Krzysztof Giannopoulos
Wojciech Jurczak
Martin Šimkovič
Anders Österborg
Luca Laurenti
Patricia Walker
Stephen Opat
Henry Chan
Hanna Ciepluch
Richard Greil
Monica Tani
Marek Trněný
Danielle M. Brander
Ian W. Flinn
Sebastian Grosicki
Emma Verner
Jennifer R. Brown
Brad S. Kahl
Paolo Ghia
Jianyong Li
Tian Tian
Lei Zhou
Carol Marimpietri
Jason C. Paik
Aileen Cohen
Jane Huang
Tadeusz Robak
Peter Hillmen
Constantine S. Tam
Source :: Transplantation and Cellular Therapy. 28:S478-S479
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Tools